Key facts
- HAE - HAEMONETICS CORP has 23 insiders with reported activity on this page.
- Net insider value flow over the last year: +$98,784.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 23 Insiders of HAEMONETICS CORP
- Symbol
- HAE on NYSE
- Location
- Boston, MA
Change
- Buy value: $98,784; sell value: $0.
- Net share flow: +1,400.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$98,784.
Buys
$98,784
Shares: 1,400
Insiders: 1
Sells
$0
Shares: 0
Insiders: 0
Net
+$98,784
Shares: +1,400
Insiders: 1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 1,400 | 0 | $98,784 | $0 | +$98,784 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
HAEMONETICS CORP executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Christopher Simon | President & CEO, Director | $25,063,517 | Median | 15 May 2026 | ||
| Michelle L. Basil | EVP and General Counsel | $3,879,202 | Median | 15 May 2026 | ||
| James Darecca | EVP, Chief Financial Officer | $3,068,463 | Median | 15 May 2026 | ||
| Josep Llorens | EVP, Global Manufacturing | $2,961,886 | Mixed | 28 May 2024 | ||
| William P. Mr. Burke | EVP, Chief Financial Officer | $2,616,839 | Mixed | 23 Aug 2021 | ||
| Laurie A. Miller | SVP, Human Resources | $2,327,668 | Median | 15 May 2026 | ||
| Roy Galvin | EVP, Chief Commercial Officer | $2,247,749 | Median | 15 May 2026 | ||
| Anila Lingamneni | EVP, Chief Technology Officer | $1,919,790 | Filing P/S | 11 Jul 2024 | ||
| Charles J. Dockendorff | Director | $1,868,308 | Mixed | 24 Jul 2025 | ||
| Robert E. Abernathy | Director | $1,863,832 | Mixed | 24 Jul 2025 | ||
| Frank Chan | EVP, Chief Operating Officer | $1,856,272 | Median | 15 May 2026 | ||
| Mark W. Kroll | Director | $1,746,853 | +$98,784 | +6% | Filing P/S | 10 Nov 2025 |
| Catherine M. Burzik | Director | $1,688,493 | Mixed | 05 Aug 2022 | ||
| Stewart W. Strong | President, Global Hospital | $1,658,565 | Filing P/S | 26 Jul 2024 | ||
| Chad M. Nikel | President, Global Plasma & BC | $1,497,657 | Mixed | 06 Aug 2021 | ||
| Ellen M. Zane | Director | $1,445,419 | Mixed | 24 Jul 2025 | ||
| Claire Pomeroy | Director | $1,258,819 | Mixed | 24 Jul 2025 | ||
| Michael J. Coyle. | Director | $1,148,546 | Mixed | 24 Jul 2025 | ||
| Lloyd E. Johnson | Director | $964,931 | Mixed | 24 Jul 2025 | ||
| Diane M. Bryant | Director | $531,670 | Mixed | 24 Jul 2025 | ||
| Dan Goldstein | VP, Corporate Controller | $384,176 | Mixed | 13 Jun 2022 | ||
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | $366,396 | Median | 15 May 2026 | ||
| Jacqueline Scanlan | SVP, Global Human Resources | $364,220 | Mixed | 07 Jun 2021 |
Top shareholders of HAEMONETICS CORP (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AQR CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Company |
6.8%
|
3,163,104
|
$253,522,786 | $0 | 31 Dec 2025 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
13F
|
Vanguard Portfolio Management · Company |
5.6%
|
2,600,145
|
$146,544,172 | $0 | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Vanguard Capital Management · Company |
5.3%
|
2,445,817
|
$137,846,246 | $0 | 31 Mar 2026 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
4.6%
|
2,203,351
|
$165,537,761 | -$36,448,193 | 30 Jun 2025 | |
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
|
Company |
4.4%
|
2,195,569
|
$135,949,632 | $0 | 31 Mar 2025 | |
| Capital Research Global Investors |
13D/G
|
— |
3.1%
|
1,577,323
|
$97,667,840 | $0 | 31 Mar 2025 | |
| Charles J. Dockendorff |
3/4/5
|
Director |
0.05%
|
25,041
|
$1,868,308 | — | 24 Jul 2025 | |
| Robert E. Abernathy |
3/4/5
|
Director |
0.05%
|
24,981
|
$1,863,832 | — | 24 Jul 2025 | |
| Mark W. Kroll |
3/4/5
|
Director |
0.05%
|
24,757
|
$1,746,853 | +$98,784 | 10 Nov 2025 | |
| Ellen M. Zane |
3/4/5
|
Director |
0.04%
|
19,373
|
$1,445,419 | — | 24 Jul 2025 | |
| Claire Pomeroy |
3/4/5
|
Director |
0.04%
|
16,872
|
$1,258,819 | — | 24 Jul 2025 | |
| Michael J. Coyle. |
3/4/5
|
Director |
0.03%
|
15,394
|
$1,148,546 | — | 24 Jul 2025 | |
| Lloyd E. Johnson |
3/4/5
|
Director |
0.03%
|
12,933
|
$964,931 | — | 24 Jul 2025 | |
| Diane M. Bryant |
3/4/5
|
Director |
0.02%
|
7,126
|
$531,670 | — | 24 Jul 2025 | |
| BlackRock, Inc. |
13F
|
Company |
12%
|
5,619,979
|
$316,742,027 | — | 31 Mar 2026 | |
| Neuberger Berman Group LLC |
13F
|
Company |
7.7%
|
3,560,918
|
$200,613,400 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
1,772,898
|
$99,920,531 | — | 31 Mar 2026 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
3%
|
1,383,004
|
$77,946,105 | — | 31 Mar 2026 | |
| River Road Asset Management, LLC |
13F
|
Company |
2.9%
|
1,327,989
|
$74,845,460 | — | 31 Mar 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.9%
|
1,326,057
|
$74,730,645 | — | 31 Mar 2026 | |
| FMR LLC |
13F
|
Company |
2.7%
|
1,275,886
|
$71,908,935 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
1,218,978
|
$68,713,808 | — | 31 Mar 2026 | |
| North Peak Capital Management, LLC |
13F
|
Company |
2.1%
|
998,953
|
$56,300,991 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2%
|
952,820
|
$53,700,964 | — | 31 Mar 2026 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
1.9%
|
890,224
|
$50,066,198 | — | 31 Mar 2026 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
1.8%
|
857,965
|
$48,354,000 | — | 31 Mar 2026 | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ |
13F
|
Company |
1.8%
|
841,017
|
$47,399,718 | — | 31 Mar 2026 | |
| Invenomic Capital Management LP |
13F
|
Company |
1.4%
|
664,729
|
$37,464,126 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
579,306
|
$32,649,687 | — | 31 Mar 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.2%
|
572,100
|
$32,243,556 | — | 31 Mar 2026 | |
| Boston Partners |
13F
|
Company |
1.2%
|
556,679
|
$31,418,477 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
1.1%
|
526,617
|
$29,680,134 | — | 31 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
512,183
|
$28,866,634 | — | 31 Mar 2026 | |
| Boston Trust Walden Corp |
13F
|
Company |
1.1%
|
501,885
|
$28,286,239 | — | 31 Mar 2026 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
1.1%
|
491,747
|
$27,715,026 | — | 31 Mar 2026 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.93%
|
430,152
|
$24,243,367 | — | 31 Mar 2026 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.9%
|
420,275
|
$23,688,000 | — | 31 Mar 2026 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.86%
|
400,917
|
$22,595,678 | — | 31 Mar 2026 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.77%
|
358,882
|
$20,226,590 | — | 31 Mar 2026 | |
| LONDON CO OF VIRGINIA |
13F
|
Company |
0.76%
|
352,807
|
$19,884,366 | — | 31 Mar 2026 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
0.74%
|
346,386
|
$19,546,740 | — | 31 Mar 2026 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.71%
|
328,909
|
$18,066,973 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.7%
|
323,585
|
$18,237,251 | — | 31 Mar 2026 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.69%
|
320,010
|
$18,035,763 | — | 31 Mar 2026 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.64%
|
298,992
|
$16,851,176 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
0.63%
|
293,439
|
$16,538,258 | — | 31 Mar 2026 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.56%
|
258,153
|
$14,549,503 | — | 31 Mar 2026 | |
| CITIGROUP INC |
13F
|
Company |
0.54%
|
251,922
|
$14,198,324 | — | 31 Mar 2026 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.5%
|
234,271
|
$13,203,514 | — | 31 Mar 2026 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.47%
|
220,672
|
$12,437,074 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for HAEMONETICS CORP
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michelle L. Basil | HAE | Common Stock | Award | 70.4% | 28,424 | 68,829 | 15 May 2026 | Direct | ||
| Michelle L. Basil | HAE | Common Stock | Tax liability | -6.72% | -2,913 | 40,405 | 15 May 2026 | Direct | ||
| Frank Chan | HAE | Common Stock | Award | 509.8% | 27,535 | 32,936 | 15 May 2026 | Direct | ||
| Frank Chan | HAE | Common Stock | Tax liability | -9.18% | -546 | 5,401 | 15 May 2026 | Direct | ||
| James Darecca | HAE | Common Stock | Award | 116.6% | 29,312 | 54,444 | 15 May 2026 | Direct | ||
| James Darecca | HAE | Common Stock | Tax liability | -9.06% | -2,505 | 25,132 | 15 May 2026 | Direct | ||
| Farris Maryanne Maunsell | HAE | Common Stock | Award | 51.9% | 2,220 | 6,501 | 15 May 2026 | Direct | ||
| Farris Maryanne Maunsell | HAE | Common Stock | Tax liability | -4.4% | -197 | 4,281 | 15 May 2026 | Direct | ||
| Roy Galvin | HAE | Common Stock | Award | 223% | 27,535 | 39,882 | 15 May 2026 | Direct | ||
| Roy Galvin | HAE | Common Stock | Tax liability | -6.65% | -879 | 12,347 | 15 May 2026 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Award | 47.6% | 13,323 | 41,300 | 15 May 2026 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Tax liability | -3.28% | -948 | 27,977 | 15 May 2026 | Direct | ||
| Christopher Simon | HAE | Common Stock | Award | 21.4% | 78,344 | 444,704 | 15 May 2026 | Direct | ||
| Christopher Simon | HAE | Common Stock | Tax liability | -2.57% | -9,681 | 366,360 | 15 May 2026 | Direct | ||
| James Darecca | HAE | Common Stock | Tax liability | -2.32% | -655 | 27,637 | 01 May 2026 | Direct | ||
| Mark W. Kroll | HAE | Common Stock | Purchase | 5.99% | $98,784 | $70.56 | 1,400 | 24,757 | 10 Nov 2025 | Direct |
| Roy Galvin | HAE | Common Stock | Tax liability | -1.12% | -145 | 12,811 | 31 Oct 2025 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Tax liability | -0.82% | -238 | 28,925 | 17 Sep 2025 | Direct | ||
| Ellen M. Zane | HAE | Common Stock | Award | 16.2% | 2,693 | 19,373 | 24 Jul 2025 | Direct | ||
| Claire Pomeroy | HAE | Common Stock | Award | 19% | 2,693 | 16,872 | 24 Jul 2025 | Direct | ||
| Mark W. Kroll | HAE | Common Stock | Award | 13% | 2,693 | 23,357 | 24 Jul 2025 | Direct | ||
| Lloyd Emerson Johnson | HAE | Common Stock | Award | 26.3% | 2,693 | 12,933 | 24 Jul 2025 | Direct | ||
| Charles J. Dockendorff | HAE | Common Stock | Award | 60.8% | 2,693 | 7,126 | 24 Jul 2025 | Direct | ||
| Michael J. Coyle | HAE | Common Stock | Award | 21.2% | 2,693 | 15,394 | 24 Jul 2025 | Direct | ||
| Diane M. Bryant | HAE | Common Stock | Award | 60.8% | 2,693 | 7,126 | 24 Jul 2025 | Direct | ||
| Robert E. Abernathy | HAE | Common Stock | Award | 12.1% | 2,693 | 24,981 | 24 Jul 2025 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Award | 12.3% | 3,195 | 29,163 | 05 Jun 2025 | Direct | ||
| Farris Maryanne Maunsell | HAE | Common Stock | Award | 146.6% | 2,662 | 4,478 | 05 Jun 2025 | Direct | ||
| Christopher Simon | HAE | Common Stock | Tax liability | -6.53% | -26,234 | 375,544 | 30 May 2025 | Direct | ||
| Christopher Simon | HAE | Common Stock | Award | 19.9% | 66,666 | 401,778 | 30 May 2025 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Tax liability | -8.08% | -2,283 | 25,968 | 30 May 2025 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Award | 38% | 7,777 | 28,251 | 30 May 2025 | Direct | ||
| James Darecca | HAE | Common Stock | Tax liability | -17.2% | -5,864 | 28,292 | 30 May 2025 | Direct | ||
| James Darecca | HAE | Common Stock | Award | 55.7% | 12,221 | 34,156 | 30 May 2025 | Direct | ||
| Michelle L. Basil | HAE | Common Stock | Tax liability | -15% | -7,469 | 42,252 | 30 May 2025 | Direct | ||
| Michelle L. Basil | HAE | Common Stock | Award | 45.5% | 15,554 | 49,721 | 30 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.